Urine analysis app uChek is about to launch a six-month, 375-patient trial with Merck for Mothers, a Merck-sponsored initiative to reduce global maternal mortality, according to ClinicalTrials[dot]gov. Researchers will test the feasability of providers using uChek to detect preeclampsia and eclampsia in pregnant women in Bangladesh, with usability of the app for healthcare professionals as a secondary outcome measure.
Pre-eclampsia and eclampsia are dangerous pregnancy complications that manifest as sudden weight gain and high blood pressure during pregnancy and seizures after pregnancy. The study will be conducted at the Hope Hospital for Women, on women who are at least 22 weeks into their pregnancy. Each woman in the study will be given both a traditional urine analysis, with a visually inspected test strip, and an analysis using uChek. Keep reading>>